*Department of Internal Medicine, The University of Texas Health Science Center

†Department of Gastroenterology, Hepatology & Nutrition

‡Department of Melanoma Medical Oncology

§Department of Thoracic, Head & Neck Medical Oncology

∥Department of Genitourinary Medical Oncology

¶Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

A.P.M. and M.S. are co-first author.

Y.W., who was the senior author of this article, developed the concept, designed the study, interpreted the results, ensured the preservation of data accuracy and integrity at all stages, agreed to be accountable for all aspects of the study, was in charge of the overall direction and planning of the study, and contributed to the writing of the manuscript, with input from all authors. A.P.M. collected the data for the study, conducted and interpreted the results of the analysis, and wrote the manuscript. M.S. did the data analysis and interpretation. I.G.O., M.A., B.S., Y.Z., K.V., H.C.Z., and A.T. critically revised the final version of the manuscript.

The data sets used and analyzed in this study are available from the corresponding author upon reasonable request.

Ethics approval for this study was granted by the MD Anderson Institutional Review Board (PA18-0472). Patient informed consent was waived for this study.

The authors declare no conflicts of interest.

Correspondence: Yinghong Wang, MD, PhD, Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. E-mail: [email protected].